caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1780798116

Javier RuizMD

Hematology-OncologyNew Windsor, NYI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
3,586
Unique beneficiaries
—
Total services
26,178
Distinct HCPCS
36
Medicare payment
$444K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 628 Hematology-Oncology providers in NY — top quintile (cohort median 883).
REFERRAL NETWORK

Where Javier Ruiz's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 19 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
ST. LUKE'S CORNWALL HOSPITAL1092,344
Bioreference Health, Llc
Clinical Laboratory · Elmwood Park, NJ
1081,578
Leila Boukhris
Internal Medicine · New Windsor, NY
38431
Chris Donikyan
Diagnostic Radiology · Middletown, NY
32343
Pamela Nguyen
Diagnostic Radiology · Middletown, NY
31222
Rehan Ahmad
Endocrinology · Newburgh, NY
22278
NPI 130686904520142
GEORGE, JOSEPH18132
Stephen Daly
Diagnostic Radiology · Middletown, NY
17167
Mehul Patel
Cardiology · Newburgh, NY
17102
Ahmad Hadid
Cardiology · New Windsor, NY
17102
Andrew Shapiro
Podiatry · Katonah, NY
1480
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
Total Rx claims
1,390
Beneficiaries
—
Total drug cost
$3.5M
Distinct drugs
44
Brand share
49.4%
Top prescribed drugs
Warfarin Sodium147 claims
Apixaban118 claims
Denosumab76 claims
Filgrastim-Sndz63 claims
Luspatercept-Aamt51 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.
QUALITY · MIPS · 2024
Final MIPS score
92.8
Quality
64.0
Cost
100.0
Improvement activities
40.0
Promoting interop.
0.0
Payment adjustment
0.75%
Group